Glyceraldehyde-3-phosphate dehydrogenase pseudogene 73 (GAPDHP73)

Glyceraldehyde-3-phosphate dehydrogenase pseudogene 73 (GAPDHP73) is a pseudogene related to the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), but it does not encode a functional protein and is generally considered non-functional in terms of classical enzyme activity. There is no evidence that "GAPDHP73" is a therapeutic target, receptor, functional enzyme, or clinically actionable molecule. The designation refers to one of many processed pseudogenes derived from the parent GAPDH gene. The parent enzyme GAPDH is highly abundant and performs key roles in glycolysis and other biological processes, but its pseudogenes—including GAPDHP73—do not encode active proteins and have no known physiological or pathological targeting value. GAPDHP73 is a non-functional, processed pseudogene derived from the retrotransposition of mRNA from the parent GAPDH gene, a fundamental glycolytic enzyme. GAPDH pseudogenes are remarkably abundant in mammalian genomes, especially in primates and rodents, likely due to repeated bursts of retrotranspositional activity in evolutionary history. Pseudogenes like GAPDHP73 are considered non-coding and do not participate in known metabolic or signaling pathways. No evidence exists for the use of GAPDHP73 (or any individual GAPDH pseudogene) as a therapeutic target, biomarker, or drug target. It is not recognized as a therapeutic target, receptor, or enzyme. There is nothing unique or actionable about this pseudogene compared to other GAPDH pseudogenes. Its listing as a "target" is incorrect; this is likely a misclassification or misunderstanding of pseudogene nomenclature. If information about canonical functional enzymes or receptors (such as GAPDH itself) is needed, further clarification is required, as pseudogenes like GAPDHP73 do not possess biological activity relevant to pharmacology or cell signaling.